|
The Centers for Medicare & Medicaid Services (CMS) has updated the RxDC drug name and therapeutic class crosswalk (RxDC Crosswalk) for the 2025 reference year. To view the document, click on the link below. You may already have the link in your bookmarks. You may need to refresh your browser before displaying the updated document.
HIOS will begin accepting submissions for the 2025 reference year on April 10th. At this time, no training webinars have been scheduled. Previously published training materials are available on our website at https://www.cms.gov/marketplace/about/oversight/other-insurance-protections/prescription-drug-data-collection-rxdc.
The deadline for submitting RxDC filings for the 2025 reference year is Monday, June 1, 2026.
| 
